Governments investing in new vaccine manufacturing plant in Toronto

The governments of Canada and Ontario are investing in a new influenza vaccine manufacturing facility in Toronto, sources tell The Canadian Press.

Sources say the federal government will invest $415 million in the partnership with Sanofi Pasteur Ltd.

Ontario’s government will contribute $55 million to the project, according to the sources.

Sanofi will invest more than $455 million as well as create and maintain 1,225 highly skilled jobs in Canada.

The company will also invest at least $79 million a year to fund Canadian research and development.

This new facility will ensure drug product formulation, fill-and-finish and inspection of flu vaccines.